Both in Pharmaceuticals
ABBVIE vs Regeneron Pharmaceuticals
Over the past year ABBV returned +35.2% and REGN returned +42.4%; their daily moves had a correlation of 0.34.
ABBV +35.2% REGN +42.4%Growth of $1, one year, split-adjusted
| Metric | ABBV | REGN |
|---|---|---|
| Price | $294.89 | $927.89 |
| Market cap | $521.11B | $95.99B |
| Today | +1.41% | +13.33% |
| 1 month | +13.4% | +26.3% |
| 6 months | +42.7% | +32.3% |
| Year to date | +29.1% | +20.2% |
| 1 year | +31.0% | +42.1% |
| Revenue growth (YoY) | +10.2% | +36.3% |
| Gross margin | 74.7% | 88.8% |
| Net margin | 21.3% | 38.1% |
| P/E (TTM) | 82.8× | 19.9× |
| Price / sales | 8.1× | 5.7× |
| Net cash | -$64.25B | $6.59B |
| Dividend yield | 2.35% | 0.41% |
| Volatility (60d) | 19.6% | 37.0% |
| Short % of float | 0.9% | 2.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).